UPDATE: RBC Capital Upgrades Seagen (SGEN) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to UPDATE: RBC Capital Upgrades Seagen (SGEN) to Outperform

Seagen Statement on Outcome of Daiichi Sankyo Arbitration

August 12, 2022 1:14 PM EDT

BOTHELL, Wash.--(BUSINESS WIRE)-- Seagen Inc. (Nasdaq: SGEN) today issued a statement regarding the outcome of the arbitration with Daiichi Sankyo Co. Ltd. (Daiichi Sankyo) relating to the parties 2008 collaboration agreement for the use of Seagens antibody-drug conjugate (ADC) technology. The arbitrator ruled in favor of Daiichi Sankyo, citing statute of limitations and disagreement with Seagen on the interpretation of the contract.

While we are disappointed with the arbitration decision, it was important for us to pursue this legal action, said Roger Dansey, M.D., interim Chief Executive Officer and Chief Medical... More